Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice

Cancer Immunology Immunotherapy

Volumn 24, Issue 1, 1987, Pages 25-36

  De Weger, Roel A ^a   Wilbrink, Bert ^a   Moberts, Roel M P ^a   Mans, Dennis ^a   Oskam, Ralph ^a   Den Otter, Willem ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; IMMUNIZATION, PASSIVE; LYMPHOMA, NON-HODGKIN; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; T-LYMPHOCYTES;

EID: 0023173660     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/BF00199829     Document Type: Article

References (32)

1. Delayed-type hypersensitivity: activation of mast cells by antigen specific T cell factors initiates the cascade of cellular interactions
2. Effects of isolated tumor lymphocytes alone and with adherent cells
3. Peritoneal cell populations during tumor rejection
4. Differentiation of immunologically specific cytotoxic macrophages into two types on the basis of radiosensitivity
5. Macrophages and anti-tumor reactions
6. Induction of specific macrophage cytotoxicity
7. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic system
8. Cytotoxicity of macrophages and monocytes
9. Cell surface antigen phenotypes and enzyme expression patterns of two murine T cell lymphomas derived from early and/or mature thymus cells
10. Mechanism of immunologically specific killing of tumor cells by macrophages
11. On the mechanism of tumor “concomitant immunity”
12. A rapid method for the isolation of functional thymus derived murine lymphocytes
13. Macrophages and lymphoid tissue in mice with concomitant tumor immunity
14. Macrophages and resistance to tumours. Influence of agents affecting macrophages and delayed type hypersensitivity on resistance to tumours inducing concomitant immunity
15. Macrophages and resistance to tumours. I. Inhibition of delayed hypersensitivity reactions by tumour cells and by soluble products affecting macrophages
16. Suppressor mechanism in tumor immunity
17. T cell-mediated suppression of the concomitant anti tumor immune response as an example of transplantation tolerance
18. Subversion of host defense mechanisms by murine tumors II. Counter influence of concomitant antitumour immunity
19. Natural cytotoxic macrophages in the peritoneal cavity of mice
20. Identification of two different types of mouse peritoneal exudate cells with ring-shaped nuclei
21. Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations
22. Specific accumulation of hapten reactive T cells in contact sensitivity reaction sites
23. Site selective homing of antigen primed lymphocyte populations can play a crucial role in the efferent limb of cell-mediated immune response in vivo
24. Immunosuppressive factors produced by tumors and their effects on the RES
25. Studies of the mechanisms for the induction of in vivo tumor immunity. VII Development of specific anti-tumor immunity in progressors and regressors
26. Host macrophage involved in systemic adoptive immunity against tumors
27. Macrophage like cells as research tools in transfer experiments
28. A macrophage factor enhancing the systemic anti-tumour effect of T lymphocytes
29. Cytochemical identification of monocytes and granulocytes
30. Immunologic responses to a murine mammary adenocarcinoma: In vitro production of specific killer cells is dependent on active T lymphocytes
31. Immunological responses to a murine mammary adenocarcinoma